Cryptosporidium parvum qPCR Kit

Cryptosporidium parvum qPCR Kit (CAT#: PRPK-031)

Product Type
Kit
Unit Size
100 T
Description
The Cryptosporidium parvum qPCR kit is specifically engineered for the in vitro detection of C. parvum genomes. It is designed to have the broadest possible detection profile while remaining specific to C. parvum. Consequently, this kit is tailored to effectively detect and isolate this species in an in vitro environment. Through extensive bioinformatic analysis using all reference data within the NCBI database, the primer and probe sequences demonstrate significant homology (>95%) with a wide range of C. parvum genomes, while not detecting other closely related species.
Nucleic Acid Target
DNA
Compatibility
All standard real-time thermal cyclers
Target Species
Cryptosporidium parvum
Detection Method
Probe based
Features
Free automatic data analyzer (Fastfinder)
Components
qPCR master mix (2x)
qPCR master mix reconstitution buffer
PPMix (10x)
NTC
Positive control
DNA internal extraction control (IEC)
Format
Lyophilized
Technology
Predesigned qPCR assays
Sample Material
DNA
Protocol Time
Approx. 60 min (from extracted NA to result)
Number of Targets
Duplex
Internal Control
No
Storage Conditions
-85 °C to -15 °C
Regulatory Status
For research use only.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Ace Therapeutics is a contract service provider focused on parasitology research, providing innovative solutions and technologies for parasite detection, genetic engineering, and drug development. We support global research institutes, universities, and pharmaceutical companies in advancing their research goals.

Contact Info
Inquiry
Copyright © Ace Therapeutics. All Rights Reserved.
Top